Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A/Leningrad/134/17/57

Author： Wareing M.D.   Tannock G.A.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.23, 2003-07, pp. : 3097-3100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain

By Wareing M.D.   Marsh G.A.   Tannock G.A.  

Vaccine, Vol. 20, Iss. 16, 2002-05 ,pp. : 2082-2090

Elsevier

Access to resources Recommend Favorite

Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon- production and local IgA response

By Tomoda T.   Morita H.   Kurashige T.   Maassab H.F.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 185-190

Elsevier

Access to resources Recommend Favorite

Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes

By de Haan A.   Geerligs H.J.   Huchshorn J.P.   van Scharrenburg G.J.M.   Palache A.M.   Wilschut J.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 155-162

Elsevier

Access to resources Recommend Favorite

Musosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

By Verweij W.R.   de Haan L.   Holtrop M.   Agsteribbe E.   Brands R.   van Scharrenburg G.J.M.   Wilschut J.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2069-2076

Elsevier

Access to resources Recommend Favorite

Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies

By Mantis N.J.   Kozlowski  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3990-4001

Elsevier

Access to resources Recommend Favorite